Sandra Prior

801 total citations
19 papers, 573 citations indexed

About

Sandra Prior is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Small Animals. According to data from OpenAlex, Sandra Prior has authored 19 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Small Animals. Recurrent topics in Sandra Prior's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Bacterial Infections and Vaccines (5 papers) and Biosimilars and Bioanalytical Methods (4 papers). Sandra Prior is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Bacterial Infections and Vaccines (5 papers) and Biosimilars and Bioanalytical Methods (4 papers). Sandra Prior collaborates with scholars based in United Kingdom, Spain and United States. Sandra Prior's co-authors include Carlos Gamazo, Juan M. Irache, Bruno Gander, Hans P. Merkle, Michael J. Corbel, Elizabeth L. Wenner, Dorothy Xing, Gordon Y. C. Cheung, R. Parton and J. G. Coote and has published in prestigious journals such as Nature Biotechnology, Infection and Immunity and International Journal of Pharmaceutics.

In The Last Decade

Sandra Prior

18 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Prior United Kingdom 12 195 137 137 80 77 19 573
Yashdeep Phanse United States 18 360 1.8× 375 2.7× 128 0.9× 53 0.7× 142 1.8× 27 871
Marjorie Vermeersch Belgium 17 148 0.8× 335 2.4× 136 1.0× 46 0.6× 157 2.0× 33 862
Ana Camila Oliveira Souza United States 15 114 0.6× 143 1.0× 75 0.5× 46 0.6× 279 3.6× 25 608
Kathleen A. Ross United States 23 385 2.0× 360 2.6× 89 0.6× 36 0.5× 208 2.7× 55 1.3k
Takako Komiya Japan 16 126 0.6× 79 0.6× 28 0.2× 55 0.7× 199 2.6× 63 801
Paul E. Makidon United States 14 267 1.4× 234 1.7× 152 1.1× 51 0.6× 163 2.1× 19 739
Dina Soroush Iran 10 164 0.8× 179 1.3× 62 0.5× 12 0.1× 93 1.2× 12 520
Naser Mohammadpour Dounighi Iran 10 140 0.7× 219 1.6× 181 1.3× 35 0.4× 52 0.7× 20 622
Shari A. Lofthouse Australia 16 252 1.3× 190 1.4× 70 0.5× 47 0.6× 56 0.7× 23 487
S. Louise Smithson United States 13 208 1.1× 175 1.3× 62 0.5× 94 1.2× 227 2.9× 21 551

Countries citing papers authored by Sandra Prior

Since Specialization
Citations

This map shows the geographic impact of Sandra Prior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Prior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Prior more than expected).

Fields of papers citing papers by Sandra Prior

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Prior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Prior. The network helps show where Sandra Prior may publish in the future.

Co-authorship network of co-authors of Sandra Prior

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Prior. A scholar is included among the top collaborators of Sandra Prior based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Prior. Sandra Prior is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sajjadi, Nancy, Laurent Mallet, Sandra Prior, et al.. (2024). Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities. Biologicals. 86. 101756–101756.
2.
Prior, Sandra, Clive Metcalfe, Simon E. Hufton, et al.. (2021). Maintaining ‘standards’ for biosimilar monoclonal antibodies. Nature Biotechnology. 39(3). 276–280. 10 indexed citations
3.
Salazar‐Fontana, Laura I., Dharmesh D. Desai, Tarik A. Khan, et al.. (2017). Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development. The AAPS Journal. 19(2). 377–385. 32 indexed citations
4.
5.
Cheung, Gordon Y. C., Sharon M. Kelly, Thomas J. Jess, et al.. (2008). Functional and structural studies on different forms of the adenylate cyclase toxin of Bordetella pertussis. Microbial Pathogenesis. 46(1). 36–42. 12 indexed citations
6.
Gamazo, Carlos, Sandra Prior, Ana Isabel Vitas, et al.. (2007). Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections. Expert Opinion on Drug Delivery. 4(6). 677–688. 24 indexed citations
7.
8.
Gamazo, Carlos, Sandra Prior, Ana Isabel Vitas, et al.. (2006). Chemical and Biological Factors in the Control of Brucella and Brucellosis. Current Drug Delivery. 3(4). 359–365. 16 indexed citations
9.
Cheung, Gordon Y. C., Dorothy Xing, Sandra Prior, et al.. (2006). Effect of Different Forms of Adenylate Cyclase Toxin ofBordetella pertussison Protection Afforded by an Acellular Pertussis Vaccine in a Murine Model. Infection and Immunity. 74(12). 6797–6805. 44 indexed citations
10.
Prior, Sandra, Michael J. Corbel, & Dorothy Xing. (2005). Development of an Approach for the Laboratory Toxicological Evaluation ofBordetella PertussisAdenylate Cyclase Genetic Toxoid Constructs as Multipurpose Vaccine. Human Vaccines. 1(4). 151–159. 6 indexed citations
11.
Prior, Sandra. (2005). Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice. Journal of Antimicrobial Chemotherapy. 55(6). 1032–1036. 29 indexed citations
12.
Prior, Sandra, et al.. (2004). Sampling and evaluation of white spot syndrome virus in commercially important Atlantic penaeid shrimp stocks. Diseases of Aquatic Organisms. 59(3). 179–185. 48 indexed citations
13.
Prior, Sandra. (2004). Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes. Journal of Antimicrobial Chemotherapy. 53(6). 981–988. 39 indexed citations
14.
Gamazo, Carlos, María J. Blanco‐Prieto, Ana Isabel Vitas, et al.. (2004). New Therapeutic Approaches for the Treatment of Brucella Infections: Gentamicin Entrapment into Drug Delivery Systems. 3(1). 43–56. 7 indexed citations
15.
Prior, Sandra, et al.. (2003). Controlled bioassay systems for determination of lethal infective doses of tissue homogenates containing Taura syndrome or white spot syndrome virus. Diseases of Aquatic Organisms. 54(2). 89–96. 61 indexed citations
16.
Prior, Sandra, et al.. (2002). In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. European Journal of Pharmaceutical Sciences. 15(2). 197–207. 111 indexed citations
17.
Prior, Sandra, et al.. (2002). Evaluation of the toxicity of recombinant Bordetella pertussis adenylate cyclase toxin preparations.. PubMed. 111. 117–27. 2 indexed citations
18.
Xing, D., et al.. (2002). Developments in reduction and replacement of in vivo toxicity and potency tests for pertussis vaccines.. PubMed. 111. 57–68. 1 indexed citations
19.
Prior, Sandra, Carlos Gamazo, Juan M. Irache, Hans P. Merkle, & Bruno Gander. (2000). Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. International Journal of Pharmaceutics. 196(1). 115–125. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yashdeep Phanse Breakdown of academic impact, for papers by Marjorie Vermeersch Breakdown of academic impact, for papers by Ana Camila Oliveira Souza Breakdown of academic impact, for papers by Kathleen A. Ross Breakdown of academic impact, for papers by Takako Komiya Breakdown of academic impact, for papers by Paul E. Makidon Breakdown of academic impact, for papers by Dina Soroush Breakdown of academic impact, for papers by Naser Mohammadpour Dounighi Breakdown of academic impact, for papers by Shari A. Lofthouse Breakdown of academic impact, for papers by S. Louise Smithson
Rankless by CCL
2026